NOMINATION COMMITTEE

This section provides the financial market, owners and other interested parties with correct, relevant and timely information about our business and our performance. Investor information is released in Swedish for regulatory reasons and translated into English on a report-to-report basis. Please contact Redsense for additional information.

A nomination committee has been established ahead of the 2025 annual general meeting in Redsense Medical AB (publ).

The nomination committee, which has been appointed in accordance with the principles adopted by the annual general meeting May 8, 2024, consists of:

Johannes Köpple, appointed by ShapeQ GmbH

Susanne Olauson, appointed by Seventh Sense Adventures Holding AB

Oscar Bergman, appointed by Swedbank Robur Fonder

Susanne Olauson, the chairman of the board is convening

The nomination committee’s task is to submit proposals to the annual general meeting regarding; nomination of the chairman at the meeting, number of board members, nomination of the chairman of the board and other members of the board, board fees and, where applicable, remuneration for committee work divided among each member, proposals for the election of auditors and auditors’ fees and, to the extent deemed necessary, proposals for changes in current instruction for the Nomination committee.

Shareholders who wish to submit proposals to the nomination committee can do so via e-mail to info@redsensemedical.com no later than January 10, 2025.

The nomination committee’s proposal will be presented in the notice to the 2025 annual general meeting and on the company’s website; www.redsensemedical.com.

The annual general meeting will be held May 14, 2025, in Halmstad.